A case of conjunctival MALT lymphoma: successfully treated with solely extended rituximab therapy.
Hande CelikerEbru TokerIsik Kaygusuz AtagunduzPublished in: International ophthalmology (2018)
Extended rituximab therapy may be an effective and well-tolerated first-line treatment option for bilateral conjunctival MALT lymphoma.